What is the initial workup for a patient suspected of having Normal Pressure Hydrocephalus (NPH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Workup for Normal Pressure Hydrocephalus (NPH)

MRI without IV contrast is the first-line imaging modality for diagnosing Normal Pressure Hydrocephalus (NPH) due to its superior ability to detect characteristic features and rule out alternative diagnoses. 1, 2

Clinical Presentation Assessment

  • NPH is characterized by a clinical triad of gait disturbance (typically occurring first), urinary incontinence, and cognitive impairment 3, 4
  • Patients typically present late in the disease course due to the slow, gradual onset of symptoms, with gait alterations occurring early and cognitive impairment developing later 1, 2
  • The prevalence of NPH is estimated at 3.7% in patients over 65 years of age, making it a potentially reversible cause of dementia 1, 5
  • Careful assessment of the patient's ability to perform routine activities of daily living is essential to establish baseline function 1

Imaging Studies

Primary Imaging: MRI Brain Without Contrast

  • MRI without IV contrast can identify classic NPH imaging findings including 1, 2:
    • Ventriculomegaly (Evan's index >0.3)
    • Narrowed posterior callosal angle (<90°)
    • Effaced sulci along high convexities
    • Widened sylvian fissures
    • Periventricular white matter changes
    • Cerebral aqueduct flow void (associated with good shunt response)
    • Disproportionately enlarged subarachnoid-space hydrocephalus (DESH) pattern

Alternative Imaging: CT Head Without Contrast

  • When MRI is contraindicated or unavailable, CT head without IV contrast can be used to identify 1, 2:
    • Ventriculomegaly
    • Narrowed posterior callosal angle
    • Effaced sulci and widened sylvian fissures
    • Periventricular white matter hypoattenuation (lower sensitivity than MRI)
  • Note that CT cannot detect cerebral aqueduct flow void and may miss small obstructing lesions 1

Supplementary Diagnostic Tests

CSF Dynamics Testing

  • CSF tap test (CSF-TT): Removal of 30-50 mL of CSF via lumbar puncture with assessment of gait and cognition before and after 3, 6
    • Positive response suggests shunt responsiveness
    • Low sensitivity but high specificity for predicting shunt response
  • For inconclusive single tap test results, consider 3, 6:
    • Repeated CSF tap test (RTT)
    • Continuous lumbar external drainage (LED) for 2-3 days

Additional Testing When Diagnosis Remains Uncertain

  • DTPA cisternography may show persistent radiotracer activity in lateral ventricles and absence over cerebral convexities on delayed imaging 1
    • Evidence is insufficient to proceed with shunting based on cisternography findings alone
  • Intracranial pressure monitoring to detect B-waves (present >50% of recording time suggests good shunt response) 3
  • CSF infusion tests to measure CSF outflow resistance 6

Laboratory Evaluation

  • Complete blood count, urinalysis, serum electrolytes (including calcium and magnesium) 1
  • Blood urea nitrogen, serum creatinine, fasting blood glucose 1
  • Thyroid-stimulating hormone to rule out metabolic causes of cognitive decline 1, 5
  • Liver function tests 1

Differential Diagnosis Considerations

  • NPH can be comorbid with other neurodegenerative diseases (present in 20-57% of NPH patients) 1, 7
  • Approximately 75% of patients with NPH severe enough to require treatment also suffer from another neurodegenerative disorder 7
  • Consider vascular dementia, Alzheimer's disease, Parkinson's disease, and other causes of gait disturbance and cognitive decline 5, 6

Pitfalls and Caveats

  • Relying solely on clinical presentation can lead to misdiagnosis, as NPH can mimic other neurodegenerative disorders 4, 7
  • A single negative CSF tap test should not exclude patients from consideration for shunt surgery due to its low sensitivity 3
  • Incomplete clinical manifestations occur in 25-50% of NPH cases, making supplementary testing crucial 3
  • Failure to diagnose NPH results in missed treatment opportunities, as approximately 80% of cases remain unrecognized and untreated 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

MRI for NPH Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.